Clinical library

Every tool, one focused workspace.

1,329 calculators and references across 60 specialties, with formula confidence shown up front.

Interactive worksheet

Get With The Guidelines-Heart Failure (GWTG-HF) Mortality Calculator

Get With The Guidelines–Heart Failure (GWTG-HF) Mortality Risk Score: Explanation and Clinical Context The GWTG-HF Risk Score is a validated tool developed from the American Heart Association's national registry to predict in-hospital mortality in patients admitted with acute decompensated heart failure (ADHF). It incorporates seven readily available clinical variables at the time of hospital admission: age, systolic

Interactive worksheet

Get With The Guidelines-Heart Failure (GWTG-HF) Rehospitalization Risk Score Calculator

Get With The Guidelines–Heart Failure (GWTG-HF) Rehospitalization Risk Score: Explanation and Clinical Context The GWTG-HF Rehospitalization Risk Score was developed from a large national registry to estimate the likelihood of 30-day readmission after discharge for patients hospitalized with heart failure. It integrates key clinical parameters available at admission and discharge, including age, blood pressure, heart

Interactive worksheet

GLOBAL LEADERS HF Subscore Calculator

GLOBAL LEADERS HF Subscore: Explanation and Clinical Context The GLOBAL LEADERS HF Subscore is intended as a prognostic tool to estimate the risk of adverse outcomes (such as mortality or heart-failure hospitalisation) in patients with chronic heart failure. It incorporates key clinical and biomarker variables (such as age, left-ventricular ejection fraction, NT-proBNP level, presence of chronic kidney disease, and r

Interactive worksheet

GLOBAL-LEADERS All-Cause Mortality Subgroup Calculator

: Explanation and Clinical Context The GLOBAL-LEADERS trial was an open‐label, all‐comers randomized study of 1 month of aspirin + ticagrelor followed by 23 months of ticagrelor monotherapy vs 12 months of DAPT followed by 12 months of aspirin in patients undergoing PCI with a biolimus‐eluting stent. The primary outcome (all-cause mortality or non-fatal myocardial infarction) did not reach statistical superiority. Se

Interactive worksheet

GUIDE-IT NT-proBNP-Guided Therapy Algorithm

: Practical explanation and clinical context The GUIDE-IT (Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure) strategy used serial NT-proBNP measurements to target a predefined goal (NT-proBNP < 1,000 pg/mL) and prompted more aggressive titration of guideline-directed medical therapy when values exceeded that threshold. The practical intention is to use NT-proBNP as an objective bi

Interactive worksheet

GWTG-HF Length of Stay (LOS) Prediction Calculator

Get With The Guidelines–Heart Failure (GWTG-HF) Length of Stay Prediction: Explanation and Clinical Context The GWTG-HF Length of Stay (LOS) model was developed from a cohort of over 100,000 hospitalizations in the American Heart Association’s Get With The Guidelines–Heart Failure registry. It provides an evidence-based estimate of the expected hospital length of stay for patients admitted with acute decompensated he